Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS

Executive Summary

Richard Eils is 1990-91 chairman of the National Association of Chain Drug Stores. Eils, president of California-based Thrifty Drug, was inaugurated at the association's 57th annual meeting at The Breakers Hotel in Palm Beach, Florida April 21-25. Elected as vice chairman was Hook-SupeRx Chairman and CEO Phil Beekman, who is succeeded as NACDS treasurer by CVS President Harvey Rosenthal. NACDS VP Finance Jim Huber reelected to his post as secretary. Only change in make-up of the NACDS board is election of Peoples Drug Store President and Chief Operating Officer David Eisenberg to replace Richard Scott of American Drug Stores.

You may also be interested in...



Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.

 

 

Big Data Offers International Benefits

The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.

UsernamePublicRestriction

Register

PS017346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel